Literature DB >> 25279176

Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis B virus infection: A field survey between 2000 and 2012.

Keisuke Amano1, Takumi Kawaguchi2, Ryoko Kuromatsu3, Atsushi Kawaguchi4, Ichiro Miyajima1, Tatsuya Ide1, Tatsuyuki Kakuma5, Michio Sata6.   

Abstract

The hepatitis B virus (HBV) carrier rate has decreased in Japan; however, the incidence of HBV infection among hepatocellular carcinoma (HCC) patients has not decreased accordingly. In this study, we aimed to assess the time trends of the clinical characteristics in HCC patients with chronic HBV infection. Between 2000 and 2012, we enrolled a total of 156 HCC patients with chronic HBV infection in our field survey. The HCC risk was evaluated using the HCC prediction score, which is constructed from the characteristics of age, presence of liver cirrhosis and serum levels of albumin, bilirubin and HBV DNA. Lifestyle factors and the presence of diabetes mellitus were also evaluated. The time trends of patient characteristics were analyzed using the Jonckheere-Terpstra proportion trend test. Among HCC patients with chronic HBV infection, the proportion of patients at high risk according to the HCC prediction score significantly decreased during the study period (P=0.0005). Similarly, the proportion of patients with liver cirrhosis, ≤3.5 g/dl serum albumin level, >4 log copies/ml serum HBV DNA level and ≥60 g/day alcohol intake were also significantly decreased. The proportion of male and obese patients was not significantly altered, whereas the proportion of elderly (≥65 years) and diabetic patients tended to increase during the study period (P=0.0654 and P=0.0528, respectively). In this study, we analyzed the time trends of the clinical characteristics in HCC patients with chronic HBV infection and demonstrated that aging and diabetes mellitus may be involved in the hepatocarcinogenesis in patients with chronic HBV infection.

Entities:  

Keywords:  aging; chronic hepatitis B; glucose metabolism disorder; liver cancer; time trend

Year:  2014        PMID: 25279176      PMCID: PMC4179821          DOI: 10.3892/mco.2014.398

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  38 in total

1.  Greater age and hepatocellular aging are independent risk factors for hepatocellular carcinoma arising from non-B non-C non-alcoholic chronic liver disease.

Authors:  Tomoki Nakajima; Toshiaki Nakashima; Junko Yamaoka; Akiko Shibuya; Eiichi Konishi; Yoshihisa Okada; Masayasu Jo; Taichirou Nishikawa; Yoshihito Itoh; Toshikazu Yoshikawa
Journal:  Pathol Int       Date:  2011-10       Impact factor: 2.534

2.  Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma.

Authors:  Ruben R Plentz; Brigitte Schlegelberger; Peer Flemming; Michael Gebel; Hans Kreipe; Michael P Manns; K Lenhard Rudolph; Ludwig Wilkens
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

Review 3.  Branched-chain amino acids as pharmacological nutrients in chronic liver disease.

Authors:  Takumi Kawaguchi; Namiki Izumi; Michael R Charlton; Michio Sata
Journal:  Hepatology       Date:  2011-06-23       Impact factor: 17.425

4.  Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.

Authors:  Eiji Ando; Ryoko Kuromatsu; Masatoshi Tanaka; Akio Takada; Nobuyoshi Fukushima; Shuji Sumie; Sakae Nagaoka; Jyunji Akiyoshi; Kinya Inoue; Takuji Torimura; Ryukichi Kumashiro; Takato Ueno; Michio Sata
Journal:  J Clin Gastroenterol       Date:  2006 Nov-Dec       Impact factor: 3.062

5.  Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

Authors:  Ting-Tsung Chang; Yun-Fan Liaw; Shun-Sheng Wu; Eugene Schiff; Kwang-Hyub Han; Ching-Lung Lai; Rifaat Safadi; Samuel S Lee; Waldemar Halota; Zachary Goodman; Yun-Chan Chi; Hui Zhang; Robert Hindes; Uchenna Iloeje; Suzanne Beebe; Bruce Kreter
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

6.  Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Authors:  Masatoshi Kudo; Namiki Izumi; Norihiro Kokudo; Osamu Matsui; Michiie Sakamoto; Osamu Nakashima; Masamichi Kojiro; Masatoshi Makuuchi
Journal:  Dig Dis       Date:  2011-08-09       Impact factor: 2.404

7.  Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan.

Authors:  Chao-Tung Chen; Jing-Yi Chen; Jing-Houng Wang; Kuo-Chin Chang; Po-Lin Tseng; Kwong-Ming Kee; Pao-Fei Chen; Lin-San Tsai; Shu-Chuan Chen; Sheng-Che Lin; Sheng-Nan Lu
Journal:  Kaohsiung J Med Sci       Date:  2013-02-09       Impact factor: 2.744

Review 8.  Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy.

Authors:  Grace Lai-Hung Wong; Vincent Wai-Sun Wong
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

9.  Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Yongfeng Wang; Jin Cheng; Chunhui Xu; Shuang Liu; Suzhen Jiang; Qiang Xu; Xiangmei Chen; Hui Zhuang; Fengmin Lu
Journal:  Liver Int       Date:  2011-12-23       Impact factor: 5.828

10.  Data mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non-hepatitis B virus/non-hepatitis C virus-related hepatocellular carcinoma.

Authors:  Takumi Kawaguchi; Tatsuyuki Kakuma; Hiroshi Yatsuhashi; Hiroshi Watanabe; Hideki Saitsu; Kazuhiko Nakao; Akinobu Taketomi; Satoshi Ohta; Akinari Tabaru; Kenji Takenaka; Toshihiko Mizuta; Kenji Nagata; Yasuji Komorizono; Kunitaka Fukuizumi; Masataka Seike; Shuichi Matsumoto; Tatsuji Maeshiro; Hirohito Tsubouchi; Toyokichi Muro; Osami Inoue; Motoo Akahoshi; Michio Sata
Journal:  Hepatol Res       Date:  2011-04-19       Impact factor: 4.288

View more
  4 in total

1.  Complications Requiring Hospital Admission and Causes of In-Hospital Death over Time in Alcoholic and Nonalcoholic Cirrhosis Patients.

Authors:  Hee Yeon Kim; Chang Wook Kim; Jong Young Choi; Chang Don Lee; Sae Hwan Lee; Moon Young Kim; Byoung Kuk Jang; Hyun Young Wo
Journal:  Gut Liver       Date:  2016-01       Impact factor: 4.519

2.  Association Between Hepatocellular Carcinoma and Type 2 Diabetes Mellitus in Chinese Hepatitis B Virus Cirrhosis Patients: A Case-Control Study.

Authors:  Huixian Han; Han Deng; Tao Han; Haitao Zhao; Feifei Hou; Xingshun Qi
Journal:  Med Sci Monit       Date:  2017-07-09

Review 3.  Diabetes and cancer: A comprehensive review.

Authors:  Manal Abudawood
Journal:  J Res Med Sci       Date:  2019-10-25       Impact factor: 1.852

Review 4.  Diabetes Mellitus and Risk of Hepatocellular Carcinoma.

Authors:  Xu Li; Xiaocong Wang; Pujun Gao
Journal:  Biomed Res Int       Date:  2017-12-12       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.